The activation of PPARβ/δ has been mainly studied in “endurance-exercise mimetics” to reduce inflammation as an obesity treatment, particularly focused on the liver, skeletal muscle, and adipose tissue [20, 21]. Here, PPARD is linked to obesity due to melanocortin 4 receptor deficiency.